Skip to main content

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  216.57
+7.84 (3.76%)
AAPL  263.66
-0.09 (-0.03%)
AMD  201.70
+10.75 (5.63%)
BAC  50.08
+0.11 (0.22%)
GOOG  303.45
-0.11 (-0.04%)
META  668.73
+13.65 (2.08%)
MSFT  410.25
+6.31 (1.56%)
NVDA  183.98
+3.93 (2.18%)
ORCL  153.34
+4.34 (2.91%)
TSLA  404.97
+12.54 (3.20%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.